Post-Transplantation Seroprotection Rates in Liver, Lung, and Heart Transplant Recipients Vaccinated Pre-Transplantation against Hepatitis B Virus and Invasive Pneumococcal Disease
Authors:
- Lise Bank HornungLHLise Bank Hornung
- Sebastian Rask HammSHSebastian Rask Hamm
- Annemette HaldAHAnnemette Hald
- Zitta Barrella HarboeZitta Barrella Harboe
- Lene Fogt LundboLLLene Fogt Lundbo
- Neval Ete WarehamNWNeval Ete Wareham
- Line Dam HeftdalLHLine Dam Heftdal
- Christina EkenbergCEChristina Ekenberg
- Stephanie BjerrumSBStephanie Bjerrum
- Jon Gitz HollerJHJon Gitz Holler
- Inger Hee Mabuza MathiesenIMInger Hee Mabuza Mathiesen
- Paul Suno KrohnPKPaul Suno Krohn
Open Access
- 25 September 2024
- Vol. 12 (10) , 1092
Abstract
Vaccination before solid organ transplantation is recommended since post-transplantation immunosuppression is known to impair vaccine responses. However, little is known about post-transplantation seroprotection rates in organ transplant recipients vaccinated pre-transplantation. We aimed to investigate the proportion of transplant recipients vaccinated against hepatitis B virus (HBV) and invasive pneumococcal disease (IPD) pre-transplantation at the time of listing for transplantation with post-transplantation seroprotection. We included 136 solid organ transplant (SOT) recipients vaccinated at the time of listing for transplantation. We investigated post-transplantation antibody concentrations against HBV and IPD. Established antibody thresholds were used to define seroprotection. The proportions of SOT recipients with post-transplantation seroprotection were 27.9% (n = 38) and 42.6% (n = 58) against HBV and IPD, respectively. Compared to completing HBV vaccination pre-transplantation, completing post-transplantation vaccination (adjusted odds ratio (aOR): 7.8, 95% CI: 2.5–24.5, p < 0.001) and incomplete vaccination (aOR: 6.3, 95% CI: 1.2–32.6, p = 0.028) were associated with non-response against HBV, after adjustment for confounders. Importantly, patients with seroprotection at the time of listing had lower odds of non-response against HBV (aOR: 0.04, 95% CI: 0.0–0.1, p < 0.001) and IPD (aOR: 0.3, 95% CI: 0.1–0.7, p = 0.007) compared to those without seroprotection. SOT recipients vaccinated pre-transplantation had low post-transplantation seroprotection rates against HBV and IPD. However, SOT recipients with seroprotection at the time of listing had lower odds of non-response, suggesting early vaccination should be a priority.Keywords
Funding Information
- Rigshospitalet, Copenhagen University Hospital
This publication has 28 references indexed in Scilit:
- Immunization of Solid Organ Transplant Candidates and RecipientsInfectious Disease Clinics of North America, 2023
- Consensus recommendations for use of maintenance immunosuppression in solid organ transplantation: Endorsed by the American College of Clinical Pharmacy, American Society of Transplantation, and the International Society for Heart and Lung TransplantationPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2022
- The impact of hepatitis B vaccination in the United States, 1999–2018Hepatology, 2021
- Comparative Efficacy of a High-Dose vs Standard-Dose Hepatitis B Revaccination Schedule Among Patients With HIVJAMA Network Open, 2021
- Prophylactic vaccination with a live-attenuated herpes zoster vaccine in lung transplant candidatesThe Journal of Heart and Lung Transplantation, 2020
- Considerable decrease in antibodies against hepatitis B surface antigen following kidney transplantationJournal of Clinical Virology, 2015
- Response to Vaccination Against Hepatitis B Virus with a Schedule of Four 40-μg Doses in Cirrhotic Patients Evaluated for Liver Transplantation: Factors Associated with a ResponseTransplantation Proceedings, 2012
- Solid organ transplantation and response to vaccinationVaccine, 2007
- Impaired anti-pneumococcal polysaccharide antibody production and invasive pneumococcal infection following heart transplantationInternational Immunopharmacology, 2006
- Hepatitis B vaccine response before and after transplantation in 55 extrahepatic biliary atresia childrenDigestive Diseases and Sciences, 1992